Notice Number: NOT-GM-19-049

Key Dates
Release Date: July 18, 2019

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to revise language regarding the maximum award project period in PAR-19-253 Focused Technology Research and Development (R01 - Clinical Trial Not Allowed) . Currently, the award project period is limited to 4 years, except for early stage investigators, who are allowed a 5-year project period. Currently, established investigators who request a 5-year project period would not be eligible for review. This Notice changes the FOA to allow all applicants to submit an application with a 5-year project period. However, established investigators should expect that awards will be made with a project period of no more than 4 years and should plan the project scope accordingly.

The FOA is modified accordingly.

Part 2. Full Text of Announcement

Section II. Award Information

Award Project Period

Current language:

The scope of the proposed project should determine the project period. The maximum project period is 4 years, 5 for early stage investigators. The grant may be renewed only one time.

Revised language:

The scope of the proposed project should determine the project period. The maximum project period is 5 years. The grant may be renewed only one time.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Paul Sammak, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]

Miles Fabian, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]

D. Craig Hopp, Ph.D.
National Center for Complementary and Integrative Health (NCCIH)
Email: [email protected]